Skip to main content

Table 1 Factors associated with progression 1 or more stages between two paired liver biopsies in 135 patients from Spain in the multivariate study

From: HAART and the liver: friend or foe?

Parameter Categories RR (95% CI) p
Undetectable HIV viremia1 Yes vs. No 0.61 (0.39-0.93) 0.03
Baseline necroinflammatory activity L2-3 vs. L0-1 1.77 (1.16-2.7) 0.009
Time between liver biopsies Per 1 year increase 1.11 (1.03-1.2) 0.01
Response to anti-HCV treatment ETR vs. no ETR 0.41 (0.19-0.88) 0.02
  1. 1Undetectable HIV RNA in ≥ 70% determinations during the follow-up.
  2. RR (95% CI): Relative risk (95% confidence interval);
  3. ETR: End of treatment response.